3SBio (TRSBF) Market Cap : $1,894 Mil (As of Apr. 29, 2024)

View and export this data going back to 2018. Start your Free Trial

What is 3SBio Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 3SBio's share price for the quarter that ended in Jun. 2023 was $0.8. 3SBio's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 2,439 Mil. Therefore, 3SBio's market cap for the quarter that ended in Jun. 2023 was $1,951 Mil.

3SBio's quarterly market cap increased from Jun. 2022 ($1,951 Mil) to Dec. 2022 ($1,951 Mil) and increased from Dec. 2022 ($1,951 Mil) to Jun. 2023 ($1,951 Mil).

3SBio's annual market cap declined from Dec. 2020 ($3,637 Mil) to Dec. 2021 ($2,018 Mil) and declined from Dec. 2021 ($2,018 Mil) to Dec. 2022 ($1,951 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 3SBio's Enterprise Value for Today is $1,735 Mil.

3SBio Market Cap Historical Data

The historical data trend for 3SBio's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Market Cap Chart

3SBio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

3,632.16

3,637.35

2,017.89

1,951.10

1,953.33

3SBio Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial															2,017.89	1,951.08	1,951.10	1,951.14	1,951.86

Competitive Comparison of 3SBio's Market Cap

For the Biotechnology subindustry, 3SBio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Market Cap distribution charts can be found below:

* The bar in red indicates where 3SBio's Market Cap falls into.

3SBio Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

3SBio's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$0.8	*	2438.87
	=	$1,951

3SBio's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	$0.8	*	2438.92
	=	$1,951

3SBio (OTCPK:TRSBF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

3SBio Market Cap Related Terms

Thank you for viewing the detailed overview of 3SBio's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio (TRSBF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

01530:Hong Kong 83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (TRSBF) Headlines

No Headlines